Ning Zhifeng, Zhu Hua, Li Feifei, Liu Qing, Liu Gefei, Tan Tao, Zhang Bo, Chen Shaobin, Li Guanwu, Huang Dongyang, Meltzer Stephen J, Zhang Hao
Laboratory for Translational Oncology basic medicine college, Hubei University of Science and Technology, Xianning, Hubei province, China ; Department of Biotherapy and Gastrointestinal Medical Oncology, Affiliated Cancer Hospital of Shantou University Medical College, Shantou, Guangdong, China ; Cancer Research Center, Shantou University Medical College, Shantou, Guangdong, China.
Department of Surgery, Davis Heart and Lung Research Institute, the Ohio State University Wexner Medical Center, Columbus, OH, USA.
Genes Cancer. 2014 Nov;5(11-12):436-44. doi: 10.18632/genesandcancer.38.
microRNA regulation network is important for the cancer genetic heterogeneity. Relative to the increasing numbers of microRNA's targets identified, upstream regulatory mechanisms that control functional microRNAs are less well-documented. Here, we investigated the function of miR-31, a pleiotropically-acting microRNA, in esophageal squamous cell cancer (ESCC). We demonstrated that miR-31 only exerted tumor-suppressive effects in TE-7 ESCC cells, but not in TE-1 ESCC cells, although both of these cell lines harbor inactive p53. Interestingly, TE-1 cells highly expressed p21, while p21 levels were virtually undetectable in TE-7 cells, suggesting a p21-dependent mechanism of miR-31-mediated tumor suppression. Accordingly, knockdown of p21 in TE-1 cells reversed the tumor suppressive actions of miR-31. In patient ESCC specimens, real-time RT-PCR analysis revealed that expression of E2F2 and STK40, two known miR-31 target oncogenes, was negatively correlated with the expression of miR-31 in a p21-dependent manner, supporting the conclusion that miR-31 only downregulates its target oncogenes when p21 levels are low. Collectively, these data suggest a novel mechanism through which the tumor-suppressive effect of miR-31 is p21-dependent. In addition, we speculate that delivery of miR-31 could provide therapeutic benefit in the personalized management of a subgroup of ESCC patients with p21-deficient tumors.
微小RNA调控网络对癌症遗传异质性至关重要。相对于已确定的越来越多的微小RNA靶标,控制功能性微小RNA的上游调控机制的文献记载较少。在此,我们研究了多效性微小RNA miR-31在食管鳞状细胞癌(ESCC)中的功能。我们证明,miR-31仅在TE-7 ESCC细胞中发挥肿瘤抑制作用,而在TE-1 ESCC细胞中则不然,尽管这两种细胞系均具有无活性的p53。有趣的是,TE-1细胞高表达p21,而在TE-7细胞中几乎检测不到p21水平,这表明miR-31介导的肿瘤抑制存在p21依赖性机制。因此,在TE-1细胞中敲低p21可逆转miR-31的肿瘤抑制作用。在患者ESCC标本中,实时RT-PCR分析显示,两个已知的miR-31靶标癌基因E2F2和STK40的表达与miR-31的表达呈p21依赖性负相关,支持了miR-31仅在p21水平较低时下调其靶标癌基因的结论。总体而言,这些数据表明了一种新机制,通过该机制miR-31的肿瘤抑制作用是p21依赖性的。此外,我们推测,miR-31的递送可为一小部分患有p21缺陷肿瘤的ESCC患者的个性化管理提供治疗益处。